Citigroup Maintains Neutral on GE HealthCare Techs, Lowers Price Target to $71

Citigroup analyst Joanne Wuensch maintains GE HealthCare Techs (NASDAQ:GEHC) with a Neutral and lowers the price target from $75 to $71.